These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5837659)

  • 1. Effects of immune serum and spleen cells on C3Hf/He tumor graft survival in Tennessee Swiss mice.
    Cruse JM; Germany WW; Dulaney AD
    Lab Invest; 1965 Aug; 14(8):1554-8. PubMed ID: 5837659
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of in vivo adsorption of immune serum to donor spleen cells on allograft rejection in X-irradiated mice.
    Cruse JM; Dulaney AD
    Z Immunitatsforsch Allerg Klin Immunol; 1966 May; 130(4):329-36. PubMed ID: 4231165
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of heterologous antilymphoid-cell serum on tumor isografts and viral leukemogenesis.
    Bremberg S; Klein E; Stjernswärd J
    Cancer Res; 1967 Nov; 27(11):2113-8. PubMed ID: 4294531
    [No Abstract]   [Full Text] [Related]  

  • 4. Migration inhibition of immune mouse spleen cells by from X-irradiated tumor-bearing mice.
    Moroson H
    Radiat Res; 1978 Jan; 73(1):192-200. PubMed ID: 622459
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulating tumor antigens versus immune serum factors in depressed concomitant immunity.
    Vaage J
    Cancer Res; 1974 Nov; 34(11):2979-83. PubMed ID: 4425091
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo and in vitro studies of the influence of the immune status of C3Hf-Bu mice on the effectiveness of local irradiation of a methylcholanthrene-induced fibrosarcoma.
    Jurin M; Suit HD
    Cancer Res; 1972 Oct; 32(10):2201-11. PubMed ID: 5080765
    [No Abstract]   [Full Text] [Related]  

  • 7. Study of destructive mechanisms of the immune response to sarcoma I allograft in mice.
    Vidrnová M; Nouza K; Nĕmec M
    Neoplasma; 1984; 31(4):369-80. PubMed ID: 6472512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed hypersensitivity to simian virus 40 tumor cells in BALB-c mice demonstrated by a radioisotopic foot-pad assay.
    Paranjpe MS; Boone CW
    J Natl Cancer Inst; 1972 Feb; 48(2):563-6. PubMed ID: 4347042
    [No Abstract]   [Full Text] [Related]  

  • 9. Altered immunogenicity of the allogeneic spleen cell preparations from rats affected by the graft-versus-host reaction.
    Medzihradský J
    Neoplasma; 1971; 18(2):225-7. PubMed ID: 4397020
    [No Abstract]   [Full Text] [Related]  

  • 10. On the graft-versus-host nature of the allogeneic effect in a tumor isograft system.
    Medzihradský J; Koníková E; Novotná L
    Neoplasma; 1973; 20(6):607-13. PubMed ID: 4149313
    [No Abstract]   [Full Text] [Related]  

  • 11. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
    Osaki T; Péron JM; Cai Q; Okamura H; Robbins PD; Kurimoto M; Lotze MT; Tahara H
    J Immunol; 1998 Feb; 160(4):1742-9. PubMed ID: 9469432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of immunosuppressor cells in rats immunized with solubilized tumor-associated antigens prepared from a methylcholanthrene-induced fibrosarcoma.
    Minami A; Kasai M; Mizushima Y; Takeichi N; Hosokawa M; Kobayashi H
    Cancer Res; 1980 Jul; 40(7):2129-34. PubMed ID: 6446378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal tissue antigens of tumor cells.
    Milas L; Suit HD
    Tex Rep Biol Med; 1969; 27(2):467-9. PubMed ID: 4900374
    [No Abstract]   [Full Text] [Related]  

  • 14. Murine splenic changes in response to syngeneic and allogeneic neoplasias.
    Braylan RC; Rumi L; Dosne Pasqualini C
    Medicina (B Aires); 1972; 32(5):505-10. PubMed ID: 4649563
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymphocyte-antibody interactions in immunological enhancement.
    Takasugi M; Hildemann WH
    Transplant Proc; 1969 Mar; 1(1):530-4. PubMed ID: 5406837
    [No Abstract]   [Full Text] [Related]  

  • 16. Specificity of in vivo tumor rejection assessed by mixing immune spleen cells with target and unrelated tumor cells.
    Röllinghoff M; Warner NL
    Proc Soc Exp Biol Med; 1973 Dec; 144(3):813-8. PubMed ID: 4543620
    [No Abstract]   [Full Text] [Related]  

  • 17. Isolation of H-2 alloantigens solubilized by the detergent NP-40.
    Schwartz BD; Nathenson SG
    J Immunol; 1971 Nov; 107(5):1363-7. PubMed ID: 5171127
    [No Abstract]   [Full Text] [Related]  

  • 18. Lectin potentiation of BCG-contact-mediated antitumor action.
    Poduval TB; Seshadri M; Sundaram K
    J Natl Cancer Inst; 1980 Nov; 65(5):909-12. PubMed ID: 6933260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological properties of transplantation immune sera. 3. Relationship between transplantation (facilitation or inhibition) and serological (anaphylaxis or cytolysis) activities.
    Kinsky RG; Voisin GA; Duc HT
    Transplantation; 1972 May; 13(5):452-60. PubMed ID: 4557795
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of blocking antibodies in immunological enhancement.
    Takasugi M; Klein E
    Immunology; 1971 Oct; 21(4):675-84. PubMed ID: 5121758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.